Chronic myelomonocytic leukemia as a transformation from polycythemia vera

Leukemia Research Reports - Tập 11 - Trang 14-16 - 2019
Mirela Andrei1, Anita Pandey2, Boris Avezbakiyev2, Jen Chin Wang2
1St Mary's Regional Medical Center, Lewiston, ME, USA
2Division of Hematology/Oncology, Brookdale University Hospital Medical Center, Brooklyn 11212, NY, USA

Tài liệu tham khảo

Arber, 2016, The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia, Blood, 127, 2391, 10.1182/blood-2016-03-643544 Barosi, 2008, International Working Group for Myeloproliferative neoplasms Research and Treatment (IWG-MRT), 22, 437 Tefferi, 2014, Long-term survival and blast transformation in molecularly annotated essential thrombocythemia, polycythemia vera, and myelofibrosis, Blood., 124, 2507, 10.1182/blood-2014-05-579136 Tam, 2008, The natural history and treatment outcome of blast phase BCR-ABL- myeloprolifeerative neoplasms, Blood, 112, 1628, 10.1182/blood-2008-02-138230 Holcombe, 1991, Chronic myelomonocytic leukemia transformation in polycythemia vera, Leukemia, 5, 606 Barraco, 2017, Monocytosis in polycythemia vera: clinical and molecular correlates, Am. J. Hematol., 92, 640, 10.1002/ajh.24740 James, 2005, A unique clonal JAK2 mutation leading to constitutive signaling causes polycythemia vera, Nature, 434, 1144, 10.1038/nature03546 Nangalia, 2013, Somatic CALR mutations in myeloproliferative neoplasms with nonmutated JAK2, N Engl J Med, 369, 2391, 10.1056/NEJMoa1312542 Arber, 2016, The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia, Blood, 127, 2391, 10.1182/blood-2016-03-643544 Wong, 2011, Gene expression profiling reveals the defining features of the classical, intermediate, and nonclassical human monocyte subsets, Blood., 118, e16, 10.1182/blood-2010-12-326355 Talati, 2016, Monocytes subset analysis accurately distinguishes CMML from MDS and is associated with a favorable MDS prognosis, Blood, 128, 2009, 10.1182/blood.V128.22.2009.2009 Finazzi, 2005, Acute leukemia in polycythemia vera. An analysis of 1638 patients enrolled in a prospective observational study, Blood, 105, 2664, 10.1182/blood-2004-09-3426 Passamonti, 2008, A dynamic prognostic model to predict survival in post-polycythemia vera myelofibrosis, Blood, 111, 3383, 10.1182/blood-2007-11-121434 Lopez, 2016, Cytogenetic abnormalities may predict transformation to acute myeloid leukemia in polycythemia vera patients, Blood, 128, 4258, 10.1182/blood.V128.22.4258.4258 Levine, 2005, The JAK2V617F activating mutation occurs in chronic myelomonocytic leukemia and acute myeloid leukemia, but not in acute lymphoblastic leukemia or chronic lymphocytic leukemia, Blood., 106, 3377, 10.1182/blood-2005-05-1898 Xu, 2013, Chronic myelomonocytic leukemia with preexisting myelodysplastic syndrome or myeloproliferative neoplasm: two stages of one disease with poor prognosis, Blood, 122, 1342, 10.1182/blood.V122.21.1342.1342 Takahashi, 2013, Clinical characteristics and outcomes of therapy-related chronic myelomonocytic leukemia, Blood, 122, 2807, 10.1182/blood-2013-03-491399